Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06478108 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Interventional Software for Multi-immunotherapy of Solid Tumors

StatusRecruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This trial is designed to investigate the safety, response rates and survival outcomes of patients with advanced solid tumors by intra-tumor (IT) injection of multiple drugs including CTLA4, PD1, and/or PDL1 antibodies combined with drugs-eluting beads loaded with IL2, chemodrug, anti-angiogenesis drug, et. al that will be recommended by an AI-based medical software named IRSW-MIM developed by a cooperating company.
Trial Details
NCT Number NCT06478108
Lead Sponsor Second Affiliated Hospital of Guangzhou Medical University
Collaborators: Immuno (Guangzhou) Biomedicine S&T Ltd
Conditions
(from sponsor)		 Lung Cancer, Liver Cancer, Solid Tumor, Adult
Related terms Liver Neoplasms, Lung Neoplasms
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov